Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 9, 2019
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
[ Mon, Sep 09th 2019
] - WOPRAI
Fri, September 6, 2019
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
[ Fri, Sep 06th 2019
] - WOPRAI
Donald Ellis Downgraded (ACRS) to Hold on, Sep 6th, 2019
Donald Ellis of JMP Securities, Downgraded "Aclaris Therapeutics, Inc." (ACRS) to Hold on, Sep 6th, 2019.
Donald has made no other calls on ACRS in the last 4 months.
There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, all agrees with Donald's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Thomas Smith of "SVB Leerink" Downgraded from Buy to Hold on, Thursday, June 27th, 2019
